AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Sugaray M 100mg/1000mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Lloyd Healthcare Pvt Ltd

Salt Composition

Sitagliptin (100mg) + Metformin (1000mg)

Overview Sugaray M 100mg/1000mg Tablet SR

Diabetace Duo 100mg/1000mg Extended-Release Tablets combine two medications to manage elevated blood glucose in individuals with type 2 diabetes. This dual-action approach helps mitigate severe diabetic complications like vision impairment and nephropathy, potentially lowering the risk of cardiovascular events. Diabetace Duo may be used as monotherapy or in conjunction with other antidiabetic agents. Optimal efficacy is achieved with a balanced diet and regular physical activity. Dosage is personalized based on individual health status, glycemic control, and concomitant medications. Consuming the tablets with food minimizes gastrointestinal discomfort. Consistent daily dosing at the same time maximizes therapeutic benefits; discontinuation should only occur under medical supervision. Adherence to the prescribed diet and exercise regimen is crucial for effective diabetes management; lifestyle choices significantly influence glycemic control. Commonly reported adverse effects include nausea, vomiting, diarrhea, stomach upset, headache, and pharyngitis. Hypoglycemia is a potential risk, especially when co-administered with insulin or sulfonylureas; patients should be educated on its recognition and management. This medication isn't suitable for all patients. Prior to commencement, inform your physician of any pre-existing kidney, liver, or heart conditions, pancreatic disorders, or significant alcohol consumption. Pregnant or lactating individuals should seek medical counsel before use. Potential drug interactions exist; disclose all medications to your doctor to ensure treatment safety. Alcohol should be limited due to its potential to reduce blood glucose levels. Your physician will monitor renal function and blood glucose levels throughout treatment.

Uses of Sugaray M 100mg/1000mg Tablet SR

Managing type 2 diabetes

Major Benefits of Sugaray M 100mg/1000mg Tablet SR:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the Sugaray M 100mg/1000mg Extended-Release tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with food.

Common Side effects of Sugaray M 100mg/1000mg Tablet SR:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Sugaray M 100mg/1000mg Tablet SR:

Consume this medication precisely as prescribed by your physician, adhering to both dosage and treatment length. Ingest the Sugaray M 100mg/1000mg Extended-Release tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with a meal.

How Sugaray M 100mg/1000mg Tablet SR works:

Sugaray M 100mg/1000mg Extended-Release tablets combine sitagliptin and metformin to manage blood glucose levels. Sitagliptin enhances insulin production by the pancreas, improves insulin utilization, and reduces hepatic glucose output. Metformin, a biguanide, decreases liver glucose production, slows intestinal glucose absorption, and increases insulin sensitivity. This dual-action approach leads to improved glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Sugaray M 100mg/1000mg SR tablets with alcohol is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Sugaray M 100mg/1000mg SR tablets during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to the fetus. A physician will assess the potential benefits against the risks before recommending this medication. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The extended-release Sugaray M 100mg/1000mg tablet is likely unsafe for breastfeeding mothers. Available evidence from humans indicates potential transfer to breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Sugaray M 100mg/1000mg SR tablets, as dose modification may be necessary. For patients with severe kidney disease, this medication is contraindicated. Consult your physician. Close monitoring of renal function is recommended during treatment.

LiverLiverUNSAFE

The use of Sugaray M 100mg/1000mg SR tablets is likely inadvisable for individuals with hepatic impairment and should be forgone. Medical guidance is recommended.

What if you forget to take Sugaray M 100mg/1000mg Tablet SR :

Should you forget to take a Sugaray M 100mg/1000mg Sustained Release tablet, administer it immediately upon remembrance. However, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take more than the prescribed dose at one time.

Facts to Know About Sugaray M 100mg/1000mg Tablet SR

LabelValue
Developing Habits No.
Type of Therapy Diabetes Management

FAQs on Sugaray M 100mg/1000mg Tablet SR

Sugaray M 100mg/1000mg SR tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Prolonged use of Sugaray M 100mg/1000mg Tablet SR can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may result in anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and ataxia), urinary issues, and cognitive changes. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Sugaray M 100mg/1000mg SR tablets may cause common side effects such as hypoglycemia, taste changes, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Sugaray M 100mg/1000mg Tablet SR is contraindicated in patients with allergies to its components or excipients, and in those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sugaray M 100mg/1000mg Tablet SR and alcohol is unsafe and may heighten the risk of lactic acidosis.
Store this medication in its original, tightly closed container, as directed on the label or packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
Sugaray M 100mg/1000mg SR tablets can cause lactic acidosis, a serious medical emergency resulting from excess blood lactic acid (also known as Metformin-Associated Lactic Acidosis or MALA). This rare side effect necessitates caution in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Sugaray M 100mg/1000mg SR tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Sugaray M 100mg/1000mg SR tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Patients allergic to Sugaray M 100mg/1000mg Tablet SR components or excipients, or with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis should not use this medication.
Combining Sugaray M 100mg/1000mg Tablet SR with alcohol is unsafe and may heighten the risk of lactic acidosis.
Sugaray M 100mg/1000mg SR tablets can cause lactic acidosis (MALA), a serious medical emergency resulting from excessive blood lactic acid. This rare side effect of metformin is avoided in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Prolonged use of Sugaray M 100mg/1000mg SR tablets can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may result in anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate this risk, supplemental vitamin B12 intake is recommended annually by some researchers.
Store this medication in its original, tightly closed container, as directed on the label. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Sugaray M 100mg/1000mg SR tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Sugaray M 100mg/1000mg SR tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Sugaray M 100mg/1000mg Tablet SR is contraindicated in patients with known allergies to its components or excipients, and those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sugaray M 100mg/1000mg SR tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Sugaray M 100mg/1000mg SR (containing metformin) can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA). This rare side effect necessitates avoiding metformin in patients with kidney disease, the elderly, or those consuming significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Prolonged use of Sugaray M 100mg/1000mg Tablet SR can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left unaddressed. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Sugaray M 100mg/1000mg Ta...
180
MRP 209
13% off